Understanding the Challenge
Pharmaceutical company GSK is exploring how generative AI can improve healthcare, particularly in areas like drug discovery and genomic analysis. However, a significant issue persists: hallucinations, where AI generates incorrect information. This is a serious concern in healthcare, as errors can lead to dangerous outcomes. GSK is addressing this problem not just during the training of AI models, but also at the time they are used in real-world applications.
Key Strategies Employed
- GSK focuses on inference-time strategies to reduce hallucinations, such as self-reflection and multi-model sampling.
- Self-reflection allows AI to critique its own responses, leading to clearer and more accurate information.
- Multi-model sampling involves using different AI models or settings to cross-check results, enhancing reliability.
- GSK highlights the importance of scaling computational resources to support these advanced techniques, which is essential for healthcare applications.
Why This Matters
GSK’s innovative strategies are not just about improving their own AI systems; they serve as a model for the entire industry. As healthcare increasingly relies on AI, ensuring accuracy and efficiency is crucial. GSK’s approach addresses the pressing need for reliable AI solutions in high-stakes environments. Their work could lead to significant advancements in drug discovery and patient care, ultimately benefiting the healthcare sector as a whole.
